Lifeline Biotechnologies, Inc. Distributes Solos Endoscopy Stock Dividend to Qualified Shareholders of Record Oct 17, 2006 10:05:00 AM RENO, NV -- (MARKET WIRE) -- 10/17/06 -- Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) announced today that the Company has distributed the Solos Endoscopy stock certificates to qualified Lifeline Biotechnologies shareholders of record, as of August 18, 2006. Lifeline Biotechnologies' shareholders will receive one share of SLSE stock for every 120 shares of LBTN stock owned as of August 18, 2006.
Lifeline Biotechnologies and Solos Endoscopy announced during a joint national teleconference their plans to target the $20 Billion minimally invasive medical market. Also, Lifeline Biotechnologies will now be implementing an aggressive acquisition strategy focusing on alternative energy projects.
Solos Endoscopy, Inc. announced, during the national teleconference, that the Company will be looking to grow their business rapidly in order to reach the $20 million to $30 million annual revenue levels Solos had experienced in the 1990s.
Lifeline Biotechnologies, Inc. recently announced that it received approximately 8.3 million shares of TrendSetter Solar Products (PINKSHEETS: TSSP) which represents approximately $400,000 in total value which is being added to the company's balance sheet. The acquisition of TrendSetter Solar Products is part of Lifeline's strategy to increase shareholder value by improving its asset valuation and the potential of issuing dividends to its shareholders.
About Lifeline Biotechnologies, Inc.:
Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community. More information is available at the company's website: www.lbtn.com.
Safe Harbor This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
CONTACT: Lifeline Biotechnologies, Inc. Investor Relations 407-884-0444 or 1-866-THE-APPLE
Posts: 1073 | Registered: Oct 2005
| IP: Logged |
-- TrendSetter Solar Products, Inc. (PINKSHEETS: TSSP) today announced record annual product shipments of $1,460,065 for the fiscal year ended October 31, 2006.
Dirk Atkinson, CEO of TrendSetter, said, "The $1,460,065.00 represents a slight increase over prior year sales of $1,455,328. However, we're encouraged at the increase, particularly due to the focus during the past year on building an infrastructure within TrendSetter. Add to that the fact that we relocated our offices and manufacturing operations, we're pleased with the increase."
Atkinson went on to say, "TrendSetter launched their new marketing campaign in January 2006 with target customers representing larger sales that required longer lead times. This strategy and these marketing and sales efforts are beginning to pay off as evidenced by the sales increases. Additionally, as this past fiscal year has progressed we have moved targeted sales efforts into the national arena."
Posts: 1442 | From: Lugano - Switzerland | Registered: Sep 2003
| IP: Logged |